Concepedia

Author

T. Wagener

European Organisation for Research and Treatment of Cancer

Also Known As

T Wagener, T. Wagener

14

Publications

691

Citations

7

H-Index

14

Concepts

All Affiliations

European Organisation for Research and Treatment of CancerRadboud University Nijmegen
TW

About

T. Wagener is an author at European Organisation for Research and Treatment of Cancer specializing in radiology, surgical oncology, and medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

266

2

Surgical Oncology

3

3

266

3

Health Sciences

2

2

158

4

Cancer Therapeutics

2

2

158

5

Orthopaedics

1

1

30

T. Wagener

×

6

Publications

635

Citations

6

H-Index

YearCitations

Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma--reduced local recurrence but no improvement in survival: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.

V. Bramwell, Jacques Rouëssé, William P. Steward,

Journal of Clinical Oncology

1994

249

A randomised phase II trial of weekly high-dose 5-fluorouracil with and without folinic acid and cisplatin in patients with advanced biliary tract carcinoma: results of the 40955 EORTC trial

Michel Ducreux, Eric Van Cutsem, Jean‐Luc Van Laethem,

European Journal of Cancer

2005

128

High-dose DTIC in advanced soft-tissue sarcomas in the adult

J. Buesa, H.T. Mouridsen, A.T. van Oosterom,

Annals of Oncology

1991

108

Darbepoetin alfa effectively maintains haemoglobin concentrations at extended dose intervals relative to intravenous or subcutaneous recombinant human erythropoietin in dialysis patients

R. Brunkhorst, J. Bommer, Jonathan Braun,

Nephrology Dialysis Transplantation

2004

77

Modulation of high-dose infusional fluorouracil by low-dose methotrexate in patients with advanced or metastatic colorectal cancer: final results of a randomized European Organization for Research and Treatment of Cancer Study.

G.H. Blijham, T. Wagener, J. Wils,

Journal of Clinical Oncology

1996

43

Phase II study of cisplatin in advanced osteogenic sarcoma. European Organization for Research on Treatment of Cancer Soft Tissue and Bone Sarcoma Group.

Marco Gasparini, Jacques Rouëssé, van Oosterom A,

PubMed

1985

30

Page 1